TLR7 Agonists Modulate the Activation of Human Conjunctival Epithelial Cells Induced by IL-1β via the ERK1/2 Signaling Pathway
Authors:
Open Access
- 8 May 2023
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 46 (4) , 1430-1444
Abstract
— Conjunctival epithelia cells play an important role in the development of allergic reactions. TLR7 agonists have been shown in studies to increase the body’s immunological tolerance by controlling the proportion of Th1/Th2 cells, although it is still unknown what impact this has on conjunctival epithelial cells. In this study, we examined the effect of TLR7 agonists on the inflammatory-activation of conjunctival epithelial cells induced by IL-1β. Quantitative PCR and ELISA analysis confirmed that TLR7 agonists could impair the proinflammatory cytokines released by the epithelia cells, whereas pro-inflammatory cytokines led to subsequent reactive oxygen species and neutrophil chemotaxis. Phosphorylation analysis and nucleocytoplasmic separation further confirmed that TLR7 agonists inhibit IL-1β-induced epithelia cells activation and ATP depletion via modulating the cytoplasmic residence of ERK1/2. Our finding indicated that TLR7 of conjunctival epithelia cells could be as a potent anti-inflammatory target for the ocular surface. And TLR7 agonists may become potential new drug for the treatment of allergic conjunctivitis.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseasesNature Communications, 2015
- The Epithelium Takes Center Stage in Allergic KeratoconjunctivitisCornea, 2010
- ERK dimers and scaffold proteins: Unexpected partners for a forgotten (cytoplasmic) taskCell Cycle, 2009
- Differential regulation and properties of MAPKsOncogene, 2007
- Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonistsNature Medicine, 2007
- Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast culturesClinical & Experimental Allergy, 2006
- Active ERK1 is dimerized in vivo: bisphosphodimers generate peak kinase activity and monophosphodimers maintain basal ERK1 activityJournal of Cell Science, 2005
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- The Role of Conjunctival Epithelial Cells in Chronic Ocular Allergic DiseaseExperimental Eye Research, 1998
- Procollagens and Inflammatory Cytokine Concentrations in Tarsal and Limbal Vernal KeratoconjunctivitisExperimental Eye Research, 1998